Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Awen Gallimore

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Journal of Hepatology|June 25, 2013
Flow cytometry makes all the differenceTom Pembroke, Awen Gallimore, Andrew Godkin
Journal of Immunological Methods|April 28, 2015
Tracking the kinetics of intrahepatic immune responses by repeated fine needle aspiration of the liverTom Pembroke, Awen Gallimore, Andrew Godkin
British Journal of Cancer|April 7, 2021
Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approachSarah N Lauder, Bart Vanhaesebroeck, Awen Gallimore
Immunology|June 22, 2019
Regulatory T cells in cancer: where are we now?Awen Gallimore, Sergio A Quezada, Rahul Roychoudhuri
The New England Journal of Medicine|December 15, 2006
T-cell costimulationMatt P Wise, Awen Gallimore, Andrew Godkin
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogenAndrew Bushell, Emma Jones, Awen Gallimore, et al.
Frontiers in Immunology|July 23, 2013
Home sweet home: the tumor microenvironment as a haven for regulatory T cellsBeatrice Ondondo, Emma Jones, Andrew Godkin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
Antigen specificity determines the pro- or antitumoral nature of CD8+ T cellsSimone Cuff, Garry Dolton, R James Matthews, et al.
Current Topics in Microbiology and Immunology|October 15, 2022
PI3K Isoform Immunotherapy for Solid TumoursJake Scott, Lauren Rees, Awen Gallimore, et al.
Immunology Letters|January 16, 2003
CD25+ regulatory T cells and tumor immunityEmma Jones, Michaela Dahm-Vicker, Denise Golgher, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Journal of Hepatology|June 25, 2013
Flow cytometry makes all the differenceTom Pembroke, Awen Gallimore, Andrew Godkin
Journal of Immunological Methods|April 28, 2015
Tracking the kinetics of intrahepatic immune responses by repeated fine needle aspiration of the liverTom Pembroke, Awen Gallimore, Andrew Godkin
British Journal of Cancer|April 7, 2021
Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approachSarah N Lauder, Bart Vanhaesebroeck, Awen Gallimore
Immunology|June 22, 2019
Regulatory T cells in cancer: where are we now?Awen Gallimore, Sergio A Quezada, Rahul Roychoudhuri
The New England Journal of Medicine|December 15, 2006
T-cell costimulationMatt P Wise, Awen Gallimore, Andrew Godkin
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogenAndrew Bushell, Emma Jones, Awen Gallimore, et al.
Frontiers in Immunology|July 23, 2013
Home sweet home: the tumor microenvironment as a haven for regulatory T cellsBeatrice Ondondo, Emma Jones, Andrew Godkin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
Antigen specificity determines the pro- or antitumoral nature of CD8+ T cellsSimone Cuff, Garry Dolton, R James Matthews, et al.
Current Topics in Microbiology and Immunology|October 15, 2022
PI3K Isoform Immunotherapy for Solid TumoursJake Scott, Lauren Rees, Awen Gallimore, et al.
Immunology Letters|January 16, 2003
CD25+ regulatory T cells and tumor immunityEmma Jones, Michaela Dahm-Vicker, Denise Golgher, et al.
Pageof 8